PCT/2000/42 : PCT Gazette, Weekly Issue No. 42, 2000 - WIPO

42/2000
19 Oct/oct 2000 PCT Gazette - Section I - Gazette du PCT 15161
COMPOSITION CONTENANT DU
SOUFRE SUBLIME PERMET-
TANT D’ALTERER LE TAUX
D’HOMODYST(E) PLASMATIQUE
CHEZ LES HUMAINS
(71, 72) KHAN, Airudin, S. [CA/CA]; Suite
204, 279 Wharncliffe Road North, London,
Ontario N6H 2C2 (CA).
(81) AE AL AM AT AU AZ BA BB BG BR BY
CA CH CN CU CZ DE DK EE ES FI GB
GD GE GH GM HR HU ID IL IN IS JP KE
KG KP KR KZ LC LK LR LS LT LU LV
MD MG MK MN MW MX NO NZ PL PT
RO RU SD SE SG SI SK SL TJ TM TR TT
UA UG US UZ VN YU ZA ZW; AP (GH
GM KE LS MW SD SL SZ TZ UG ZW);
EA (AM AZ BY KG KZ MD RU TJ TM);
EP (AT BE CH CY DE DK ES FI FR GB
GR IE IT LU MC NL PT SE); OA (BF BJ
CF CG CI CM GA GN GW ML MR NE SN
TD TG).
(51) 7 A61K 33/04
(11) WO 00/61155 (13) A1
(21) PCT/CA99/00893
(22) 27 Sep/sep 1999 (27.09.1999)
(25) en (26) en
(30) 2,265,921 8 Apr/avr 1999
(08.04.1999)
(30) 60/128,358 8 Apr/avr 1999
(08.04.1999)
CA
US
(43) 19 Oct/oct 2000 (19.10.2000)
(54) COMPOSITION, CONTAINING SU-
BLIMED SULFUR, FOR THE TREAT-
MENT OF LACTOSE INTOLERANCE
COMPOSITION, CONTENANT DU
SOUFRE SUBLIME, PERMETTANT
DE TRAITER L’INTOLERANCE AU
LACTOSE
(71, 72) KHAN, Airudin, S. [CA/CA]; Suite
204, 279 Wharncliffe Road North, London,
Ontario N6H 2C2 (CA).
(81) AE AL AM AT AU AZ BA BB BG BR BY
CA CH CN CU CZ DE DK EE ES FI GB
GD GE GH GM HR HU ID IL IN IS JP KE
KG KP KR KZ LC LK LR LS LT LU LV
MD MG MK MN MW MX NO NZ PL PT
RO RU SD SE SG SI SK SL TJ TM TR TT
UA UG US UZ VN YU ZA ZW; AP (GH
GM KE LS MW SD SL SZ TZ UG ZW);
EA (AM AZ BY KG KZ MD RU TJ TM);
EP (AT BE CH CY DE DK ES FI FR GB
GR IE IT LU MC NL PT SE); OA (BF BJ
CF CG CI CM GA GN GW ML MR NE SN
TD TG).
(51) 7 A61K 35/00
(11) WO 00/61156 (13) A2
(21) PCT/US00/07514
(22) 20 Mar/mar 2000 (20.03.2000)
(25) en (26) en
(30) 09/289,576 9 Apr/avr 1999
(09.04.1999)
(43) 19 Oct/oct 2000 (19.10.2000)
US
(54) METHODS OF TREATING SCHIZO-
PHRENIA
METHODES DE TRAITEMENT DE LA
SCHIZOPHRENIE
(63) US 09/289,576 (CIP)
9 Apr/avr 1999 (09.04.1999)
(71) TITAN PHARMACEUTICALS, INC.
[US/US]; Post Office Plaza, 50 Division
Street, Suite 503, Somerville, NJ 08876
(US).
(for all designated States except / pour tous
les États désignés sauf US)
(72, 75) ALLEN, Richard, C. [US/US]; 155
Hillcrest Road, Flemington, NJ 08822 (US).
CORNFELDT, Michael [US/US]; 22 Canterbury
Way, Morristown, NJ 07960 (US).
(74) BUFFINGER, Nicholas, S. et al. / etc.;
Morrison & Foerster LLP, 755 Page Mill
Road, Palo Alto, CA 94304–1018 (US).
(81) AE AL AM AT AU AZ BA BB BG BR BY
CA CH CN CR CU CZ DE DK DM EE ES
FI GB GD GE GH GM HR HU ID IL IN
IS JP KE KG KP KR KZ LC LK LR LS LT
LU LV MD MG MK MN MW MX NO NZ
PL PT RO RU SD SE SG SI SK SL TJ TM
TR TT UA UG US UZ VN YU ZA ZW;
AP (GH GM KE LS MW SD SL SZ TZ UG
ZW); EA (AM AZ BY KG KZ MD RU TJ
TM); EP (AT BE CH CY DE DK ES FI FR
GB GR IE IT LU MC NL PT SE); OA (BF
BJ CF CG CI CM GA GN GW ML MR NE
SN TD TG).
(51) 7 A61K 35/00, 38/19, 35/14, 39/02, 38/17,
31/70, 39/00, 39/085, 39/106, 48/00, 9/48,
A61P 37/00 // C07K 19/00, C12N 15/62
(11) WO 00/61157 (13) A1
(21) PCT/US00/09270
(22) 7 Apr/avr 2000 (07.04.2000)
(25) en (26) en
(30) 09/290,029 9 Apr/avr 1999
(09.04.1999)
(43) 19 Oct/oct 2000 (19.10.2000)
US
(54) METHODS FOR SKEWING THE BA-
LANCE BETWEEN TH1 AND TH2 IM-
MUNE RESPONSES
PROCEDES SERVANT A BIAI-
SER L’EQUILIBRE ENTRE DES
REPONSES IMMUNES DE TH1 ET
TH2
(71) PANACEA PHARMACEUTICALS, LLC
[US/US]; 640 Sasco Hill Road, Fairfield, CT
06430 (US).
(72) BOTTOMLY, H., Kim; 177 Livingston
Street, New Haven, CT 06511 (US). CA-
PLAN, Michael, J.; 1217 Racebrook Road,
Woodbridge, CT 06525 (US). SOSIN, Howard,
B.; 640 Sasco Hill Road, Fairfield, CT
06430 (US).
(74) JARRELL, Brenda, Herschbach; Choate,
Hall & Stewart, Exchange Place, 53 State
Street, Boston, MA 02109 (US).
(81) AE AL AM AT AU AZ BA BB BG BR BY
CA CH CN CU CZ DE DK EE ES FI GB
GD GE GH GM HR HU ID IL IN IS JP KE
KG KP KR KZ LC LK LR LS LT LU LV
MD MG MK MN MW MX NO NZ PL PT
RO RU SD SE SG SI SK SL TJ TM TR TT
UA UG UZ VN YU ZA ZW; AP (GH GM
KE LS MW SD SL SZ TZ UG ZW); EA
(AM AZ BY KG KZ MD RU TJ TM); EP
(ATBECHCYDEDKESFIFRGBGR
IE IT LU MC NL PT SE); OA (BF BJ CF
CG CI CM GA GN GW ML MR NE SN TD
TG).
(51) 7 A61K 35/12, 45/00, C12N 5/10
(11) WO 00/61158 (13) A2
(21) PCT/JP00/02420
(22) 13 Apr/avr 2000 (13.04.2000)
(25) ja (26) ja
(30) 11/154200 14 Apr/avr 1999
(14.04.1999)
(43) 19 Oct/oct 2000 (19.10.2000)
(54) METHOD FOR RENEWING LIVING
BEING PERMANTLY
PROCEDE DE RENOUVELLEMENT
PERMANENT D’UN ETRE VIVANT
(71, 72) ARAI, Izumi [JP/JP]; 19–16, Senjumidoricho
2–chome, Adachi–ku, Tokyo
120–0044 (JP).
(81) AL AM AT AU AZ BA BB BG BR BY CA
CH CN CU CZ DE DK DZ EE ES FI GB
GE GH GM HR HU ID IL IN IS JP KE KG
KR KZ LC LK LR LS LT LU LV MA MD
MG MK MN MW MX NO NZ PL PT RO
RU SD SE SG SI SK SL TJ TM TR TT TZ
UA UG US UZ VN YU ZA ZW; AP (GH
GM KE LS MW SD SL SZ TZ UG ZW);
EA (AM AZ BY KG KZ MD RU TJ TM);
EP (AT BE CH CY DE DK ES FI FR GB
GR IE IT LU MC NL PT SE); OA (BF BJ
CF CG CI CM GA GN GW ML MR NE SN
TD TG).
Published / Publiée :(i)
(51) 7 A61K 35/78, A61P 29/00, 35/00, 25/02
(11) WO 00/61159 (13) A1
(21) PCT/CH00/00214
(22) 12 Apr/avr 2000 (12.04.2000)
(25) de (26) de
(30) 99810308.9 14 Apr/avr 1999
(14.04.1999)
(30) 1519/99 19 Aug/août 1999
(19.08.1999)
(30) 99810750.2 20 Aug/août 1999
(20.08.1999)
(43) 19 Oct/oct 2000 (19.10.2000)
JP
EP
CH
EP
(54) MEDICAMENT FOR INHIBITING NF–
B
MEDICAMENT POUR INHIBER LE
FACTEUR DE TRANSMISSION NF– B